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Partner up to invade
A 
secretory complex and a cytoskeletal 
polarity protein cooperate to make tumor 
cells more invasive, according to new 
work from Sakurai-Yageta et al.
To burrow into nearby tissue, tumor cells 
create membrane protrusions called invado-
podia. Within invadopodia, vesicles accumu-
late that contain metalloproteinase enzymes 
needed to degrade the extracellular matrix. 
Because a secretory complex called the exo-
cyst is known to link exocytic vesicles to grow-
ing membranes, the team tested the effect of 
depleting particular exocyst subunits in breast 
cancer cells. They showed that the cells were 
less able to degrade the matrix on which they 
were cultured and became less invasive.
The same subunits bound to a protein called 
IQGAP1, which links actin and microtubules at the 
leading edge of migrating cells, accumulate in 
invadopodia and have been implicated in tumor 
invasion. Linkage of IQGAP1 and the exocyst was 
needed for metalloproteinase accumulation at the 
invadopodia, though it remains to be determined 
whether the exocyst directly targets the vesicles. 
Two important promoters of actin cytoskeletal 
assembly, Cdc42 and RhoA, promoted the 
association of IQGAP1 with the exocyst, through 
direct contact with exocyst subunits. Knock-
down of either Cdc42 or RhoA also reduced 
matrix degradation and tumor invasiveness.
The authors suggest that by linking IQGAP1 
to the exocyst, the cell ensures coordination of 
two central features of tumor invasion: actin re-
organization at the invadopodia and exocytosis 
of protein-degrading enzymes. 
Sakurai-Yageta, M., et al. 2008. J. Cell Biol. 
doi:10.1083/jcb.200709076.
A better way to see splicing partners
S
plicing factor interactions have been well-characterized in vitro, but 
less so in vivo. Ellis et al. have now used live cell imaging techniques 
to study these interactions in vivo and to discover where in the 
nucleus they occur.
Coimmunoprecipitation can’t capture the dynamic nature of protein 
interactions, and the resolution of conventional fl  uorescence microscopy is 
too poor to distinguish truly interacting proteins from ones that are merely 
close to each other. In contrast, a positive FRET (fl  uorescence resonance 
energy transfer) signal implies two proteins are close enough to interact, and 
photobleaching or FLIM (fl  uorescence lifetime imaging microscopy) can 
detect changes in an interacting pair over time.
Using these techniques, the authors confi  rmed that the splice site protein, 
SF2/ASF, and the 5′ splice site factor, U1 70K, interact in a type of nuclear body 
called a “speckle” and, to a lesser extent, in the nucleoplasm. When transcription 
was blocked, nucleoplasmic, but not speckle-localized, interactions were dimin-
ished. This fi  nding bolsters the case for speckles as storage or assembly sites for 
splicing factors rather than sites of transcription-associated splicing.
The same localization and response to transcription inhibition was seen 
for interactions between SF2/ASF and the 3′ splice site binder, U2AF35. 
But apparently not all splicing factors accumulate in speckles: interactions 
between HCC1 and either U2AF35 or U2AF65 were most prominent in the 
nucleoplasm, even when transcription was blocked.
There is clearly still much to uncover about splicing factor interactions in vivo, 
but by using FLIM-FRET, the authors have a powerful tool to dig deeper. 
Ellis, J.D., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200710051.
The mitochondrial connection
A
dd two, and perhaps three, more skills to the portfolio of multi-
talented plectin, say Winter et al.: one isoform of the protein 
anchors mitochondria to the cytoskeleton and keeps these organelles 
in shape, and may also create a platform for signaling.
Plectin is a “cytolinker” protein responsible for connecting intermediate 
ﬁ  laments with, among other things, actin microﬁ  laments, microtubules, and 
myosin motors. Its versatility arises from alternative splicing—almost a dozen 
isoforms are known, which differ at their N termini, affecting the substrates to 
which they can attach. One isoform, P1b, has been found targeted to mito-
chondria, but the signiﬁ  cance of this linkage has been unclear.
The authors have now found that P1b links mitochondria to the interme-
diate ﬁ  lament protein, vimentin. P1b colocalized with vimentin, and loss of 
P1b reduced the amount of vimentin in mitochondrial extracts. Loss of P1b 
also dramatically altered mitochondrial shape, increasing the number of mito-
chondria that were highly elongated. Elongation was not caused by alterations 
in mitochondrial membrane potential, 
mass, or fusion dynamics. But it may 
have resulted from a reduction in pro-
tein kinase C-δ activation, as this was 
apparent in cells that lacked P1b, 
through unknown mechanisms. PKC-δ 
promotes mitochondrial ﬁ  ssion,  and 
the authors suggest that intermediate 
ﬁ  lament–linked P1b may serve as a scaffold for recruiting PKC-δ, and 
perhaps other signaling molecules, to regulate mitochondrial ﬁ  ssion. 
Winter, L., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200710151.
IQGAP1 and exocyst component Sec8 colocalize 
at invadopodia.
In the absence of P1b, mitochondrial 
networks become more tubular (right).